InSysBio announces its participation in the Thirty-third PAGE Meeting which is to be held from 4-6 June, 2025, at the Thessaloniki Concert Hall in Thessaloniki, Greece. InSysBio team is going to present its QSP modeling services & software to optimize drug development at the Booth #10 in the upper foyer and 2 posters in frames of the Meeting, namely:

Poster Session I, Wednesday, Jun 4, 10:30 AM - 12:00 PM:

• S-04 "LikelihoodProfiler.jl: A Unified Package for Practical Identifiability Analysis and Confidence Intervals Estimation" by Ivan Borisov, Aleksander Demin, Evgeny Metelkin

Poster Session II, Wednesday, Jun 4, 3:30 PM - 5:00 PM:

• S-05 "Enhancing QSP Model Creation and Validation with CYTOCON DB: A Standardized Repository for In Vivo Cell and Cytokine Baseline Concentrations" by Vladislav Leonov, Ekaterina Mogilevskaya, Elita Gerasimuk, Nikolay Pervushin, Nail Gizzatkulov, Oleg Demin

Check out our Booth #10 and posters at PAGE 2025! 

About InSysBio

InSysBio is a group of Quantitative Systems Pharmacology (QSP) companies located in Limassol, Cyprus (INSYSBIO CY Ltd) and Edinburgh, UK (INSYSBIO UK LIMITED). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio’s cutting-edge QSP approach has already become a part of the drug development process implemented by our strategic partners: there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry and innovative biotech companies. For more information about InSysBio, its solutions and services, visit www.insysbio.com

Share